Inhibition of LKB1 promotes metastasis and invasion in breast cancer and other cancer types (Zhuang et al., 2006; Li et al., 2014), and we have previously reported that LKB1 expression regulates invasive and metastatic properties of basal-like breast cancers (Rhodes et al., 2015). Here, STK11 is linked to breast carcinoma.